Droperidol-induced neuroleptic malignant syndrome

被引:7
|
作者
Edgar, J [1 ]
机构
[1] Royal Infirm, Dept Anaesthesia, Edinburgh EH3 9YW, Midlothian, Scotland
来源
HOSPITAL MEDICINE | 1999年 / 60卷 / 06期
关键词
D O I
10.12968/hosp.1999.60.6.1140
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:448 / 449
页数:2
相关论文
共 50 条
  • [31] Paliperidone-Induced Neuroleptic Malignant Syndrome
    Nayak, Raghavendra Bheemappa
    Bhogale, Govind S.
    Patil, Nanasaheb M.
    Chate, Sameeran S.
    Pandurangi, Aditya Anand
    Shetageri, Veda N.
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2011, 23 (01) : E14 - E15
  • [32] Fluphenazine induced neuroleptic malignant syndrome in a horse
    Schmitz, R
    Grabner, A
    PFERDEHEILKUNDE, 2006, 22 (03): : 309 - 313
  • [33] Olanzapine-Induced Malignant Neuroleptic Syndrome
    Saritas, Tuba Berra
    Cankaya, Baris
    Yosunkaya, Alper
    TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION, 2014, 42 (05) : 288 - 291
  • [34] QUETIAPINE-INDUCED NEUROLEPTIC MALIGNANT SYNDROME
    Freire Lucas, R. M.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [35] Amisulpride-induced neuroleptic malignant syndrome
    Abay, Ercan
    Kose, Rugul
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2007, 19 (04) : 488 - 489
  • [36] Risperidone-induced neuroleptic malignant syndrome
    Bajjoka, I
    Patel, T
    OSullivan, T
    ANNALS OF EMERGENCY MEDICINE, 1997, 30 (05) : 698 - 700
  • [37] Neuroleptic malignant syndrome induced by aripiprazole depot
    Chicote, A. Contreras
    Diaz, E.
    Dominguez, J. Garcia
    Grandas, F.
    NEUROLOGIA, 2023, 38 (05): : 374 - 375
  • [38] AMOXAPINE-INDUCED NEUROLEPTIC MALIGNANT SYNDROME
    MADAKASIRA, S
    DICP-THE ANNALS OF PHARMACOTHERAPY, 1989, 23 (01): : 50 - &
  • [39] Olanzapine induced "typical" neuroleptic malignant syndrome
    Goveas, JS
    Hermida, A
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (01) : 101 - 102
  • [40] Risperidone-induced neuroleptic malignant syndrome
    Sharma, R
    Trappler, B
    Ng, YK
    Leeman, CP
    ANNALS OF PHARMACOTHERAPY, 1996, 30 (7-8) : 775 - 778